Mark E. Bunnage
EVP, Chief Scientific Officer at Vertex Pharmaceuticals · 10 reported transactions in 1 company · latest trade May 15, 2026
Their trades
Sold | May 15, 2026 | May 15, 2026 close $436.95 → Oct 29, 2026 close $540.00. S&P 500 +4.5% over the same days. | ||
Sold | Feb 25, 2026 | Feb 25, 2026 close $483.05 → Oct 29, 2026 close $540.00. S&P 500 +11.4% over the same days. | ||
Sold | Feb 18, 2026 | Feb 18, 2026 close $470.31 → Oct 29, 2026 close $540.00. S&P 500 +12.5% over the same days. | ||
Sold | Feb 17, 2026 | Feb 17, 2026 close $477.32 → Oct 29, 2026 close $540.00. S&P 500 +13.1% over the same days. | ||
Sold | Feb 11, 2026 | Feb 11, 2026 close $461.24 → Oct 29, 2026 close $540.00. S&P 500 +11.6% over the same days. |
$15K
May 15, 2026 close $436.95 → Oct 29, 2026 close $540.00. S&P 500 +4.5% over the same days.
$301.5K
Feb 25, 2026 close $483.05 → Oct 29, 2026 close $540.00. S&P 500 +11.4% over the same days.
$559.9K
Feb 18, 2026 close $470.31 → Oct 29, 2026 close $540.00. S&P 500 +12.5% over the same days.
$1.19M
Feb 17, 2026 close $477.32 → Oct 29, 2026 close $540.00. S&P 500 +13.1% over the same days.
$930.5K
Feb 11, 2026 close $461.24 → Oct 29, 2026 close $540.00. S&P 500 +11.6% over the same days.